Cachan, France

Lorraine Montel

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Paris Sciences Et Lettres, Sorbonne Université. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorraine Montel: Innovator in Colloidal Science

Introduction

Lorraine Montel is a distinguished inventor based in Cachen, France. She has made significant contributions to the field of colloidal science, particularly through her innovative methods for producing functionalized colloidal particles. Her work has implications in various scientific and industrial applications.

Latest Patents

Montel holds a patent for "Colloidal particles functionalized homogeneously by biomolecules." This invention relates to a method for producing a colloid that comprises functionalized liquid colloidal particles. The patent also covers the uses of such colloids, showcasing her expertise in this specialized area.

Career Highlights

Throughout her career, Lorraine Montel has worked with notable institutions such as Paris Sciences et Lettres and the Centre National de la Recherche Scientifique. Her experience in these prestigious organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Montel has collaborated with esteemed colleagues, including Lea Pinon and Jacques Fattaccioli. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Lorraine Montel's innovative work in colloidal science and her patent for functionalized colloidal particles highlight her role as a leading inventor in her field. Her contributions continue to influence scientific research and applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…